XENE - Xenon Pharmaceuticals Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5258.25M
Enterprise Value 3171.99M
Trailing P/E N/A
Forward P/E 1-5.11
PEG Ratio (5 yr expected) 1-0.09
Price/Sales (ttm)N/A
Price/Book (mrq)3.05
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-4.15

Trading Information

Stock Price History

Beta (3Y Monthly) 1.39
52-Week Change 3-1.96%
S&P500 52-Week Change 36.70%
52 Week High 315.92
52 Week Low 35.41
50-Day Moving Average 39.87
200-Day Moving Average 39.14

Share Statistics

Avg Vol (3 month) 382.08k
Avg Vol (10 day) 342.81k
Shares Outstanding 525.77M
Float 17.97M
% Held by Insiders 13.38%
% Held by Institutions 175.58%
Shares Short (Jun 28, 2019) 4492.56k
Short Ratio (Jun 28, 2019) 44.69
Short % of Float (Jun 28, 2019) 41.98%
Short % of Shares Outstanding (Jun 28, 2019) 41.91%
Shares Short (prior month May 31, 2019) 4533.63k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-34.44%
Return on Equity (ttm)-69.67%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-23.63M
EBITDA -41.45M
Net Income Avi to Common (ttm)-38.8M
Diluted EPS (ttm)-1.81
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)110.43M
Total Cash Per Share (mrq)4.28
Total Debt (mrq)16.44M
Total Debt/Equity (mrq)17.81
Current Ratio (mrq)17.57
Book Value Per Share (mrq)3.28

Cash Flow Statement

Operating Cash Flow (ttm)-35.17M
Levered Free Cash Flow (ttm)-21.08M